Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,051 | 4,732 | 5,221 | 11,571 | 4,155 |
| Depreciation Amortization | 326 | 162 | 582 | 649 | 436 |
| Accounts receivable | 148 | 398 | -714 | -982 | -366 |
| Other Working Capital | 3,769 | 3,552 | -843 | -1,529 | -1,208 |
| Other Operating Activity | -8,881 | -6,953 | -19,348 | -20,956 | -11,658 |
| Operating Cash Flow | $-1,588 | $1,891 | $-15,103 | $-11,247 | $-8,641 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,406 | -710 | -1,965 | -1,385 | -1,005 |
| Sale Of Investment | N/A | N/A | 5,000 | 5,000 | 5,000 |
| Purchase Sale Intangibles | -18 | -7 | N/A | -13 | -9 |
| Other Investing Activity | -18 | -7 | -156 | -137 | -132 |
| Investing Cash Flow | $-1,424 | $-716 | $2,879 | $3,478 | $3,863 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -171 | -171 | 54 | 137 | 138 |
| Debt Repayment | -210 | N/A | -1,110 | -1,110 | -1,110 |
| Common Stock Issued | 5,108 | 3,240 | 14,038 | 10,223 | 6,518 |
| Other Financing Activity | -149 | -91 | -235 | -150 | -81 |
| Financing Cash Flow | $4,579 | $2,978 | $12,746 | $9,101 | $5,464 |
| Beginning Cash Position | 7,464 | 7,464 | 6,942 | 6,942 | 6,942 |
| End Cash Position | 9,031 | 11,617 | 7,464 | 8,274 | 7,627 |
| Net Cash Flow | $1,567 | $4,153 | $522 | $1,332 | $685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,588 | 1,891 | -15,103 | -11,247 | -8,641 |
| Capital Expenditure | -1,406 | -710 | -1,965 | -1,385 | -1,005 |
| Free Cash Flow | -2,994 | 1,181 | -17,068 | -12,632 | -9,646 |